Therapeutic Potential of Sodium Selenite Application for Promoting Radioactive Iodine Avidity in Papillary Thyroid

Ji Min Oh1,2, Ramya Lakshmi Rajendran1,2,3, Prakash Gangadaran1,2

  • 1Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu, 41944, Republic of Korea, knu.ac.kr.

Abstract

Insights

Sodium selenite may improve radioactive iodine therapy for differentiated thyroid cancer. It enhances radioactive iodine uptake and cancer cell killing by upregulating key markers and downregulating specific signaling pathways.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Radioactive iodine therapy is crucial for differentiated thyroid cancer but often fails in dedifferentiated tumors.
  • Dedifferentiation leads to reduced sodium iodide symporter expression and poor prognosis.
  • Selenium's role in thyroid cancer and its potential to enhance radioactive iodine uptake require further investigation.

Purpose of the Study:

  • To determine if sodium selenite enhances radioactive iodine avidity in papillary thyroid cancer cells.
  • To assess the impact of sodium selenite on radioactive iodine therapeutic efficacy.
  • To analyze signaling pathway alterations induced by sodium selenite.

Main Methods:

  • Papillary thyroid cancer cells were treated with sodium selenite.
  • Radioactive iodine avidity was measured.
  • Expression of sodium iodide symporter, thyroid-specific proteins, and transcription factors was analyzed.
  • Signaling pathways (MAPK, PI3K-AKT, GSK-3β/β-catenin) were assessed.

Main Results:

  • Sodium selenite upregulated the sodium iodide symporter, thyroid-specific proteins, and transcription factors.
  • This resulted in increased radioactive iodine avidity and cytotoxicity.
  • Sodium selenite downregulated MAPK, PI3K-AKT, and GSK-3β/β-catenin signaling pathways.

Conclusions:

  • Sodium selenite shows potential as an adjuvant therapy to improve radioactive iodine avidity in papillary thyroid cancer.
  • It enhances the effectiveness of radioactive iodine treatment by modulating key cellular mechanisms.

Related Concept Videos

Affinity and Avidity01:41

Affinity and Avidity

Overview
38.8K
Radioactive Decay and Radiometric Dating02:48

Radioactive Decay and Radiometric Dating

Radioactivity is a spontaneous disintegration of an unstable nuclide and is a random process, as all the nuclei in the sample do not decay simultaneously. The number of disintegrations per unit time is called the activity (A), which is directly proportional to the number of nuclei in the sample. The decay constant (λ) is an average probability of decay per nucleus in unit time.
37.1K
Radioactivity and Nuclear Equations03:18

Radioactivity and Nuclear Equations

Nuclear chemistry is the study of reactions that involve changes in nuclear structure. The nucleus of an atom is composed of protons and, except for hydrogen, neutrons. The number of protons in the nucleus is called the atomic number (Z) of the element, and the sum of the number of protons and the number of neutrons is the mass number (A). Atoms with the same atomic number but different mass numbers are isotopes of the same element.
A nuclide of an element has a specific number of protons and...
27.2K
Papillary Dermis01:11

Papillary Dermis

Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen...
5.6K
Types of Radioactivity03:23

Types of Radioactivity

The most common types of radioactivity are α decay, β decay, γ decay, neutron emission, and electron capture.
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
19.6K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K